Global Hematology Diagnostics Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2028

Hematology is the branch of science that includes study of blood, blood-forming organs and various blood diseases and disorders. Blood diseases and disorders includes various indications such as leukemia, hemophilia, sickle-cell anemia and lymphoma. Hematology diagnostics deals with the physiology, etiology, pathology, and prognosis of blood related diseases and disorders. Hematology diagnostics focuses largely on lymphatic organs and bone marrow to diagnose platelet and blood count irregularities.

Request Covid - 19 Impact

Global Hematology Diagnostics Market: Dynamics

Rapidly rising geriatric population and increasing incidence of blood related disorders and diseases among individuals worldwide is expected to boost demand for hematology diagnostics and drives growth of the global market over the forecast period. Increasing research and development activities to innovate technologically advanced diagnostics devices is also anticipated to propel growth of the target market over the forecast period. Developed medical infrastructure and availability of favorable reimbursement policies in developed countries is projected to bolster growth of the global hematology diagnostics market over the forecast period.

However, high cost of initial setup for hematology diagnostics devices and increasing product recalls are some of the major factors may hamper growth of the target market during the forecast period to certain extent

Global Hematology Diagnostics Market: Segment Analysis

The global hematology diagnostics market is segmented on the basis of product type, end user and region.

On the basis of product type, the target market is segmented into devices and consumables. Device segment is further bifurcated into hematology analyzers, flow cytometers and others. The hematology analyzer sub-segment is categorized into fully-automated and semi-automated analyzers. Consumable segment contributes a major share in terms of revenue and expected to register a significant growth rate in the global market over the forecast period owing to increasing consumption of consumables and reagents. Among the end users, hospital segment dominates the target market and anticipated to maintain its position during the forecast period.

Global Hematology Diagnostics Market: Regional Analysis

The North America hematology diagnostics market dominate the global market in terms of value, owing to increasing adoption of advanced hematology diagnostics technologies by various end users. Europe is also contributed second highest share in the global target market and register a moderate growth over the forecast period. The Asia Pacific market is expected to register a significant growth rate over the forecast period owing to developing medical infrastructure and adoption of advanced technology based devices in countries in the region.

Global Hematology Diagnostics Market: Segmentation

Segmentation by Product Type:

• Devices

• • Hematology Analyzers
    • Fully-automated Hematology Analyzers
    • Semi-automated Hematology Analyzers
  • Flow Cytometers
  • Others

• Consumables
  • Reagents
  • Stains
  • Controls & Calibrators
  • Others

Segmentation by End User:

• Diagnostic Laboratories
• Hospitals and Clinics
• Academic Institutes
• Others

Segmentation by Region:

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East and Africa

• Abbott Laboratories
• Sysmex Corporation
• Mindray Medical International Limited,
• Bio-Rad Laboratories, Inc.
• Hoffmann-La Roche Ltd
• HemoCue AB
• Siemens Healthineers
• Danaher (Beckman Coulter, Inc.)
• HORIBA, Ltd.
• Diatron MI PLC